Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin SR in Diabetic Peripheral Neuropathy
NCT06383702Phase 3Not yet recruiting
- Sponsor
- CSPC Ouyi Pharmaceutical
- Start
- May 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of pregabalin in diabetic peripheral neuropathy (DPN), sponsored by CSPC Ouyi Pharmaceutical. Planned start May 2024; status: not yet recruiting.
02
Drugs
pregabalin
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT06383702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06383702.